Spire Wealth Management’s Guardant Health GH Stock Holding History

Spire Wealth Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-61	Closed	-$1.26K	–	2287
2024 Q1	$1.26K	Sell	61 -5	-8%	-$107	﹤0.01%	2173
2023 Q4	$1.53K	Hold	66	–	–	﹤0.01%	2195
2023 Q3	$1.96K	Sell	66 -150	-69%	-$5.28K	﹤0.01%	2143
2023 Q2	$7.73K	Buy	216 +150	+227%	+$4.31K	﹤0.01%	1889
2023 Q1	$1.55K	Buy	+66	New	+$1.89K	﹤0.01%	2312
2022 Q3	–	Sell	-66	Closed	-$3K	–	2343
2022 Q2	$3K	Sell	66 -61	-48%	-$3.02K	﹤0.01%	2265
2022 Q1	$8K	Sell	127 -495	-80%	-$33.9K	﹤0.01%	2102
2021 Q4	$62K	Buy	622 +456	+275%	+$47.2K	﹤0.01%	1614
2021 Q3	$21K	Hold	166	–	–	﹤0.01%	1840
2021 Q2	$21K	Sell	166 -509	-75%	-$68.5K	﹤0.01%	1847
2021 Q1	$95K	Buy	+675	New	+$102K	﹤0.01%	1418

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Spire Wealth Management's GH Position: Q2 2024 in Review

Spire Wealth Management sold out of Guardant Health (GH) in Q2 2024, closing a stake of 61 shares — an estimated $1.26K sold.

Spire Wealth Management first reported a position in GH in Q1 2021 and held it in 11 quarters. The position peaked at $95K in Q1 2021. 282 funds tracked by Wall St. Rank hold GH as of Q2 2024.

Spire Wealth Management reported no remaining Guardant Health position as of Q2 2024 after selling out during the quarter.
Spire Wealth Management sold 61 Guardant Health shares in Q2 2024, an estimated $1.26K.
Spire Wealth Management first reported a position in Guardant Health in Q1 2021 and held it in 11 quarters.
Spire Wealth Management's Guardant Health position peaked at $95K in Q1 2021.
282 funds tracked by Wall St. Rank held Guardant Health as of Q2 2024.

Based on Spire Wealth Management's 13F filing for Q2 2024, filed 31 Jul 2024.